Revenue (Annual)

Revenue: The sum of all revenue fields included for a company's operating activities.

Bio-Rad Laboratories, Inc. (BIO.B) had Revenue of $2.57B for the most recently reported fiscal year, ending 2024-12-31.

Quarterly Annual

Figures for fiscal year ending 2024-12-31

Income Statement Financials
Revenue	$2.57B
Net Income	$-1.84B
Cost of Goods Sold	$1.19B
Gross Profit	$1.38B
Operating Expenses	$2.30B
Operating Income	$269.00M
Non-Operating Income/Expense	$-2.61B
Pre-Tax Income	$-2.34B
Normalized Pre-Tax Income	$314.30M
Income after Taxes	$-1.84B
Income from Continuous Operations	$-1.84B
Consolidated Net Income/Loss	$-1.84B
Normalized Income after Taxes	$1.38B
EBIT	$269.00M
EBITDA	$269.00M
Weighted-Average Shares Outstanding (Basic)	28.21M
Weighted-Average Shares Outstanding (Diluted)	28.21M
Earnings per Share (EPS) (Basic)	$-65.36
Earnings per Share (EPS) (Diluted)	$-65.36
Balance Sheet Financials
Current Assets	$3.03B
Property, Plant, and Equipment	$528.10M
Long-Term Assets	$6.33B
Total Assets	$9.36B
Current Liabilities	$467.80M
Long-Term Debt	$1.20B
Long-Term Liabilities	$2.33B
Total Liabilities	$2.79B
Common Equity	$6.57B
Tangible Shareholders Equity	$5.87B
Shareholders Equity	$6.57B
Common Shares Outstanding	28.01M
Cash Flow Statement Financials
Cash Flow from Operating Activities	$455.20M
Cash Flow from Investing Activities	$-160.20M
Cash Flow from Financial Activities	$-218.80M
Beginning Cash	$404.40M
End Cash	$489.80M
Increase/Decrease in Cash	$85.40M
Stock-Based Compensation	--
Common Stock Dividends Paid	--
Preferred Stock Dividends Paid	--
Fundamental Metrics & Ratios
Current Ratio	6.48
Non-Performing Assets / Total Loans	--
Loan Loss Reserves / Non-Performing Loans	--
Debt to Capital Ratio	0.15
Debt to Equity Ratio	0.18
Gross Margin	53.73%
Operating Margin	10.48%
EBIT Margin	10.48%
EBITDA Margin	10.48%
Pre-Tax Profit Margin	-91.27%
Profit Margin	-71.86%
Free Cash Flow	$289.70M
Loss Ratio	--
Expense Ratio	--
Combined Ratio	--
Asset Turnover	0.27
Inventory Turnover	1.56
Receiveable Turnover	5.67
Days Sales in Receivables	64.35
Return on Equity	-28.07%
Return on Tangible Equity	-31.44%
Return on Assets	-19.69%
Return on Investments	-23.74%
Book Value Per Share	$234.53
Free Cash Flow per Share	$10.27
Operating Cash Flow per Share	$16.13

Data from Zacks Investment Research, Inc.